Advanced in Angiosarcoma of the Scalp

Dr. Atrayee Basu-Mallick

Hematology Oncology | Oncology
Jefferson University Physicians
925 Chestnut St, Suite 3, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Advanced in Angiosarcoma of the Scalp
Jefferson University Physicians
925 Chestnut St, Suite 3, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Atrayee Basu-Mallick is a Hematologist Oncology specialist and an Oncologist in Philadelphia, Pennsylvania. Dr. Basu-Mallick is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma of the Scalp. Her top areas of expertise are Bone Tumor, Colorectal Cancer, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Pancreaticoduodenectomy.

Her clinical research consists of co-authoring 21 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in PA
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

JEFFERSON UNIVERSITY PHYSICIANS
925 Chestnut St, Suite 3, Philadelphia, PA 19107
Other Locations
JEFFERSON UNIVERSITY PHYSICIANS
834 Walnut St, Suite 110, Philadelphia, PA 19107
JEFFERSON UNIVERSITY PHYSICIANS
111 S 11th St, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
Enrollment Status: Recruiting
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: INBRX-109
Study Phase: Phase 2
Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-cell Lymphomas
Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-cell Lymphomas
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug, Procedure, Genetic
Study Drugs: Bendamustine, Ofatumumab, Carboplatin, Etoposide
Study Phase: Phase 1/Phase 2
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Drugs: Olaratumab, Nab-paclitaxel, Gemcitabine
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trial

21 Total Publications

Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma.
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma.
Journal: JCO precision oncology
Published: July 02, 2025
Similar Doctors
Distinguished in Angiosarcoma of the Scalp
Dr. Margaret Von-Mehren
Oncology | Transplant Surgery
Distinguished in Angiosarcoma of the Scalp
Dr. Margaret Von-Mehren
Oncology | Transplant Surgery

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (3.8 miles away)
215-707-5030
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Margaret Von-Mehren is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Von-Mehren is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma of the Scalp. Her top areas of expertise are Gastrointestinal Stromal Tumor, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Retroperitoneal Liposarcoma.

Distinguished in Angiosarcoma of the Scalp
Dr. Lee Hartner
Hematology | Oncology
Distinguished in Angiosarcoma of the Scalp
Dr. Lee Hartner
Hematology | Oncology

Abramson Cancer Center Radnor

145 King Of Prussia Road, Floor 2, Suite 200 North, 
Radnor, PA 
 (12.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lee Hartner is a Hematologist and an Oncologist in Radnor, Pennsylvania. Dr. Hartner is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma of the Scalp. His top areas of expertise are Adult Soft Tissue Sarcoma, Retroperitoneal Liposarcoma, Liposarcoma, Gastrostomy, and Endoscopy. Dr. Hartner is currently accepting new patients.

Advanced in Angiosarcoma of the Scalp
Laetitia D. Simeral, NP
Nurse Practitioner | Hematology | Oncology
Advanced in Angiosarcoma of the Scalp
Laetitia D. Simeral, NP
Nurse Practitioner | Hematology | Oncology

Penn Hematology/Oncology Pennsylvania Hospital

719 Manning St, Farm Journal Building, 2nd Floor, 
Philadelphia, PA 
 (0.7 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Laetitia Simeral is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Ms. Simeral is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma of the Scalp. Her top areas of expertise are Alveolar Soft Part Sarcoma, Liposarcoma, Fibrosarcoma, and Myxoid Liposarcoma. Ms. Simeral is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Basu-Mallick's expertise for a condition
ConditionClose
    View All 22 Distinguished Conditions
    View All 18 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile